Leading the realization of our vision.
The ARIAD management team is the right mix of talent, expertise and experience to lead our company as we work to transform the lives of cancer patients with breakthrough medicines. In addition to people with proven scientific and medical backgrounds, our team includes seasoned individuals who know how to build and run a commercial business.
Executive Leadership Team
Harvey J. Berger, M.D.
Chairman and Chief Executive Officer
David L. Berstein, Esq.
Senior Vice President and Chief Intellectual Property Counsel
Daniel M. Bollag, Ph.D.
Senior Vice President of Regulatory Affairs and Quality
Maria E. Cantor
Senior Vice President, Corporate Affairs and Human Resources
Timothy P. Clackson, Ph.D.
President of Research and Development and Chief Scientific Officer
Hugh M. Cole
Senior Vice President and Chief Business Officer
Thomas J. DesRosier, Esq.
Executive Vice President, Chief Legal and Administration Officer, and Secretary
Martin J. Duvall
Executive Vice President and Chief Commercial Officer
Edward M. Fitzgerald
Executive Vice President, Chief Financial Officer and Treasurer
Frank G. Haluska, M.D., Ph.D.
Senior Vice President, Clinical R&D and Chief Medical Officer
Senior Management Team
Vice President, Finance and Controller
David C. Dalgarno, Ph.D.
Vice President, Research Technologies
Jonathan E. Dickinson
Vice President, European Operations and General Manager, ARIAD Pharmaceuticals (Europe), Sarl
Shirish Hirani, Ph.D.
Vice President, Drug Development
Vice President, Marketing
Ronald K. Knickerbocker, Ph.D.
Vice President, Biomedical Data Sciences and Information
Vice President, Quality
Yan Moore, M.D.
Vice President, Medical Affairs
Christopher K. Murray, Ph.D.
Vice President, Technical Operations
Victor M. Rivera, Ph.D.
Vice President, Preclinical and Translational Research
William C. Shakespeare, Ph.D.
Vice President, Drug Discovery
Piet A.M Vervaet, M.D.
Vice President, Drug Safety and Pharmacovigilance